Gary S. Gillheeney, Sr.
Principal executive officer pay for Gary S. Gillheeney, Sr., by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
Organogenesis Holdings Inc. (ORGO) FY2020–FY2025
Lagged peersTSR -56% vs peer group -5% over FY2020–FY2025
Paid for declineCAP $5,102,714→$15,180,181 while $100 invested went $156.55→$68.79 (FY2020–FY2025)
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2020 | $2.5M | $5.1M |
| FY2021 | $4.4M | $6.3M |
| FY2022 | $6.0M | -$1.0M |
| FY2023 | $6.2M | $10.5M |
| FY2024 | $7.0M | $12.5M |
| FY2025 | $6.8M | $15.2M |
The company's "$100 invested" index ran $156.55 at FY2020 → $68.79 by FY2025 — an annualized return of -15.2%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: -15.2%/yr at ORGO ( FY2020–FY2025). See the CEO track-record ranking for context.